FDA Approves First Gene Therapy for Adult Metastatic Synovial Sarcoma!

preview_player
Показать описание
🧬 Exciting advancements in sarcoma treatment! The FDA has granted accelerated approval to Tecelra, the first gene therapy for adults with unresectable or metastatic synovial sarcoma. This milestone highlights the promise of adaptive cell therapy and T-cell treatments, showing a 40% survival rate. Join Shushan Hovsepyan on OncoDaily for her latest 5-Minute Sarcoma Talk with Sandra D’Angelo, where they discuss promising immunotherapies. Stay tuned to OncoDaily for more breakthroughs in oncology! 🌟
#oncology #cancer #cancertreatment #cancerresearch #sarcoma #genetherapy #clinicaltrials #clinicalresearch

About OncoDaily
OncoDaily is a world-leading oncology media platform, which is based in the United States and features the cancer related latest news, insights, and patient stories from around the globe. The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”
Рекомендации по теме